DMAY yields 4.45% · MRK yields 3.25%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, DMAY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DMAY + MRK for your $10,000?
The investment objective of the FT Vest U.S. Equity Deep Buffer ETF - May (the "Fund") is to seek to provide investors with returns (before fees and expenses) that match the price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to a predetermined upside cap of 12.30% while providing a buffer (before fees and expenses) against Underlying ETF losses between -5% and -30% over the period from May 19, 2025 to May 15, 2026.
Full DMAY Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.